Literature DB >> 23462924

Combined and interactive effects of environmental and GWAS-identified risk factors in ovarian cancer.

Celeste Leigh Pearce1, Mary Anne Rossing, Alice W Lee, Roberta B Ness, Penelope M Webb, Georgia Chenevix-Trench, Susan M Jordan, Douglas A Stram, Jenny Chang-Claude, Rebecca Hein, Stefan Nickels, Galina Lurie, Pamela J Thompson, Michael E Carney, Marc T Goodman, Kirsten Moysich, Estrid Hogdall, Allan Jensen, Ellen L Goode, Brooke L Fridley, Julie M Cunningham, Robert A Vierkant, Rachel Palmieri Weber, Argyrios Ziogas, Hoda Anton-Culver, Simon A Gayther, Aleksandra Gentry-Maharaj, Usha Menon, Susan J Ramus, Louise Brinton, Nicolas Wentzensen, Jolanta Lissowska, Montserrat Garcia-Closas, Leon F A G Massuger, Lambertus A L M Kiemeney, Anne M Van Altena, Katja K H Aben, Andrew Berchuck, Jennifer A Doherty, Edwin Iversen, Valerie McGuire, Patricia G Moorman, Paul Pharoah, Malcolm C Pike, Harvey Risch, Weiva Sieh, Daniel O Stram, Kathryn L Terry, Alice Whittemore, Anna H Wu, Joellen M Schildkraut, Susanne K Kjaer.   

Abstract

BACKGROUND: There are several well-established environmental risk factors for ovarian cancer, and recent genome-wide association studies have also identified six variants that influence disease risk. However, the interplay between such risk factors and susceptibility loci has not been studied.
METHODS: Data from 14 ovarian cancer case-control studies were pooled, and stratified analyses by each environmental risk factor with tests for heterogeneity were conducted to determine the presence of interactions for all histologic subtypes. A genetic "risk score" was created to consider the effects of all six variants simultaneously. A multivariate model was fit to examine the association between all environmental risk factors and genetic risk score on ovarian cancer risk.
RESULTS: Among 7,374 controls and 5,566 cases, there was no statistical evidence of interaction between the six SNPs or genetic risk score and the environmental risk factors on ovarian cancer risk. In a main effects model, women in the highest genetic risk score quartile had a 65% increased risk of ovarian cancer compared with women in the lowest [95% confidence interval (CI), 1.48-1.84]. Analyses by histologic subtype yielded risk differences across subtype for endometriosis (Phet < 0.001), parity (Phet < 0.01), and tubal ligation (Phet = 0.041).
CONCLUSIONS: The lack of interactions suggests that a multiplicative model is the best fit for these data. Under such a model, we provide a robust estimate of the effect of each risk factor that sets the stage for absolute risk prediction modeling that considers both environmental and genetic risk factors. Further research into the observed differences in risk across histologic subtype is warranted.

Entities:  

Mesh:

Year:  2013        PMID: 23462924      PMCID: PMC3963289          DOI: 10.1158/1055-9965.EPI-12-1030-T

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  33 in total

1.  Relation of contraceptive and reproductive history to ovarian cancer risk in carriers and noncarriers of BRCA1 gene mutations.

Authors:  V McGuire; A Felberg; M Mills; K L Ostrow; R DiCioccio; E M John; D W West; A S Whittemore
Journal:  Am J Epidemiol       Date:  2004-10-01       Impact factor: 4.897

2.  Low-dose oral contraceptives: protective effect on ovarian cancer risk.

Authors:  J Royar; H Becher; J Chang-Claude
Journal:  Int J Cancer       Date:  2001-11-20       Impact factor: 7.396

3.  Multiple births and risk of epithelial ovarian cancer.

Authors:  D C Whiteman; M F Murphy; L S Cook; D W Cramer; P Hartge; P A Marchbanks; P C Nasca; R B Ness; D M Purdie; H A Risch
Journal:  J Natl Cancer Inst       Date:  2000-07-19       Impact factor: 13.506

Review 4.  Risk prediction models for familial breast cancer.

Authors:  Antonis C Antoniou; Douglas F Easton
Journal:  Future Oncol       Date:  2006-04       Impact factor: 3.404

5.  Differences in risk factors for epithelial ovarian cancer by histologic type. Results of a case-control study.

Authors:  H A Risch; L D Marrett; M Jain; G R Howe
Journal:  Am J Epidemiol       Date:  1996-08-15       Impact factor: 4.897

6.  A genome-wide association study identifies a new ovarian cancer susceptibility locus on 9p22.2.

Authors:  Honglin Song; Susan J Ramus; Jonathan Tyrer; Kelly L Bolton; Aleksandra Gentry-Maharaj; Eva Wozniak; Hoda Anton-Culver; Jenny Chang-Claude; Daniel W Cramer; Richard DiCioccio; Thilo Dörk; Ellen L Goode; Marc T Goodman; Joellen M Schildkraut; Thomas Sellers; Laura Baglietto; Matthias W Beckmann; Jonathan Beesley; Jan Blaakaer; Michael E Carney; Stephen Chanock; Zhihua Chen; Julie M Cunningham; Ed Dicks; Jennifer A Doherty; Matthias Dürst; Arif B Ekici; David Fenstermacher; Brooke L Fridley; Graham Giles; Martin E Gore; Immaculata De Vivo; Peter Hillemanns; Claus Hogdall; Estrid Hogdall; Edwin S Iversen; Ian J Jacobs; Anna Jakubowska; Dong Li; Jolanta Lissowska; Jan Lubiński; Galina Lurie; Valerie McGuire; John McLaughlin; Krzysztof Medrek; Patricia G Moorman; Kirsten Moysich; Steven Narod; Catherine Phelan; Carole Pye; Harvey Risch; Ingo B Runnebaum; Gianluca Severi; Melissa Southey; Daniel O Stram; Falk C Thiel; Kathryn L Terry; Ya-Yu Tsai; Shelley S Tworoger; David J Van Den Berg; Robert A Vierkant; Shan Wang-Gohrke; Penelope M Webb; Lynne R Wilkens; Anna H Wu; Hannah Yang; Wendy Brewster; Argyrios Ziogas; Richard Houlston; Ian Tomlinson; Alice S Whittemore; Mary Anne Rossing; Bruce A J Ponder; Celeste Leigh Pearce; Roberta B Ness; Usha Menon; Susanne Krüger Kjaer; Jacek Gronwald; Montserrat Garcia-Closas; Peter A Fasching; Douglas F Easton; Georgia Chenevix-Trench; Andrew Berchuck; Paul D P Pharoah; Simon A Gayther
Journal:  Nat Genet       Date:  2009-08-02       Impact factor: 38.330

7.  Hormonal risk factors for ovarian cancer in premenopausal and postmenopausal women.

Authors:  Patricia G Moorman; Brian Calingaert; Rachel T Palmieri; Edwin S Iversen; Rex C Bentley; Susan Halabi; Andrew Berchuck; Joellen M Schildkraut
Journal:  Am J Epidemiol       Date:  2008-02-25       Impact factor: 4.897

8.  Risk factors for invasive epithelial ovarian cancer: results from a Swedish case-control study.

Authors:  Tomas Riman; Paul W Dickman; Staffan Nilsson; Nestor Correia; Hans Nordlinder; Cecilia M Magnusson; Ingemar R Persson
Journal:  Am J Epidemiol       Date:  2002-08-15       Impact factor: 4.897

9.  Common variants at 19p13 are associated with susceptibility to ovarian cancer.

Authors:  Kelly L Bolton; Jonathan Tyrer; Honglin Song; Susan J Ramus; Maria Notaridou; Chris Jones; Tanya Sher; Aleksandra Gentry-Maharaj; Eva Wozniak; Ya-Yu Tsai; Joanne Weidhaas; Daniel Paik; David J Van Den Berg; Daniel O Stram; Celeste Leigh Pearce; Anna H Wu; Wendy Brewster; Hoda Anton-Culver; Argyrios Ziogas; Steven A Narod; Douglas A Levine; Stanley B Kaye; Robert Brown; Jim Paul; James Flanagan; Weiva Sieh; Valerie McGuire; Alice S Whittemore; Ian Campbell; Martin E Gore; Jolanta Lissowska; Hanna P Yang; Krzysztof Medrek; Jacek Gronwald; Jan Lubinski; Anna Jakubowska; Nhu D Le; Linda S Cook; Linda E Kelemen; Angela Brooks-Wilson; Angela Brook-Wilson; Leon F A G Massuger; Lambertus A Kiemeney; Katja K H Aben; Anne M van Altena; Richard Houlston; Ian Tomlinson; Rachel T Palmieri; Patricia G Moorman; Joellen Schildkraut; Edwin S Iversen; Catherine Phelan; Robert A Vierkant; Julie M Cunningham; Ellen L Goode; Brooke L Fridley; Susan Kruger-Kjaer; Jan Blaeker; Estrid Hogdall; Claus Hogdall; Jenny Gross; Beth Y Karlan; Roberta B Ness; Robert P Edwards; Kunle Odunsi; Kirsten B Moyisch; Julie A Baker; Francesmary Modugno; Tuomas Heikkinenen; Ralf Butzow; Heli Nevanlinna; Arto Leminen; Natalia Bogdanova; Natalia Antonenkova; Thilo Doerk; Peter Hillemanns; Matthias Dürst; Ingo Runnebaum; Pamela J Thompson; Michael E Carney; Marc T Goodman; Galina Lurie; Shan Wang-Gohrke; Rebecca Hein; Jenny Chang-Claude; Mary Anne Rossing; Kara L Cushing-Haugen; Jennifer Doherty; Chu Chen; Thorunn Rafnar; Soren Besenbacher; Patrick Sulem; Kari Stefansson; Michael J Birrer; Kathryn L Terry; Dena Hernandez; Daniel W Cramer; Ignace Vergote; Frederic Amant; Diether Lambrechts; Evelyn Despierre; Peter A Fasching; Matthias W Beckmann; Falk C Thiel; Arif B Ekici; Xiaoqing Chen; Sharon E Johnatty; Penelope M Webb; Jonathan Beesley; Stephen Chanock; Montserrat Garcia-Closas; Tom Sellers; Douglas F Easton; Andrew Berchuck; Georgia Chenevix-Trench; Paul D P Pharoah; Simon A Gayther
Journal:  Nat Genet       Date:  2010-09-19       Impact factor: 41.307

10.  Effect of screening on ovarian cancer mortality: the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Randomized Controlled Trial.

Authors:  Saundra S Buys; Edward Partridge; Amanda Black; Christine C Johnson; Lois Lamerato; Claudine Isaacs; Douglas J Reding; Robert T Greenlee; Lance A Yokochi; Bruce Kessel; E David Crawford; Timothy R Church; Gerald L Andriole; Joel L Weissfeld; Mona N Fouad; David Chia; Barbara O'Brien; Lawrence R Ragard; Jonathan D Clapp; Joshua M Rathmell; Thomas L Riley; Patricia Hartge; Paul F Pinsky; Claire S Zhu; Grant Izmirlian; Barnett S Kramer; Anthony B Miller; Jian-Lun Xu; Philip C Prorok; John K Gohagan; Christine D Berg
Journal:  JAMA       Date:  2011-06-08       Impact factor: 157.335

View more
  25 in total

Review 1.  Preclinical Models of Ovarian Cancer: Pathogenesis, Problems, and Implications for Prevention.

Authors:  Anthony N Karnezis; Kathleen R Cho
Journal:  Clin Obstet Gynecol       Date:  2017-12       Impact factor: 2.190

2.  Association of aspirin and NSAID use with risk of colorectal cancer according to genetic variants.

Authors:  Hongmei Nan; Carolyn M Hutter; Yi Lin; Eric J Jacobs; Cornelia M Ulrich; Emily White; John A Baron; Sonja I Berndt; Hermann Brenner; Katja Butterbach; Bette J Caan; Peter T Campbell; Christopher S Carlson; Graham Casey; Jenny Chang-Claude; Stephen J Chanock; Michelle Cotterchio; David Duggan; Jane C Figueiredo; Charles S Fuchs; Edward L Giovannucci; Jian Gong; Robert W Haile; Tabitha A Harrison; Richard B Hayes; Michael Hoffmeister; John L Hopper; Thomas J Hudson; Mark A Jenkins; Shuo Jiao; Noralane M Lindor; Mathieu Lemire; Loic Le Marchand; Polly A Newcomb; Shuji Ogino; Bethann M Pflugeisen; John D Potter; Conghui Qu; Stephanie A Rosse; Anja Rudolph; Robert E Schoen; Fredrick R Schumacher; Daniela Seminara; Martha L Slattery; Stephen N Thibodeau; Fridtjof Thomas; Mark Thornquist; Greg S Warnick; Brent W Zanke; W James Gauderman; Ulrike Peters; Li Hsu; Andrew T Chan
Journal:  JAMA       Date:  2015-03-17       Impact factor: 56.272

3.  Timing of births and oral contraceptive use influences ovarian cancer risk.

Authors:  Anna H Wu; Celeste Leigh Pearce; Alice W Lee; Chiuchen Tseng; Anjali Jotwani; Prusha Patel; Malcolm C Pike
Journal:  Int J Cancer       Date:  2017-09-12       Impact factor: 7.396

4.  Circulating estrogens and postmenopausal ovarian and endometrial cancer risk among current hormone users in the Women's Health Initiative Observational Study.

Authors:  Britton Trabert; Sally B Coburn; Roni T Falk; JoAnn E Manson; Louise A Brinton; Margery L Gass; Lewis H Kuller; Thomas E Rohan; Ruth M Pfeiffer; Lihong Qi; Marcia L Stefanick; Nicolas Wentzensen; Garnet L Anderson; Xia Xu
Journal:  Cancer Causes Control       Date:  2019-09-21       Impact factor: 2.506

Review 5.  Going to extremes: determinants of extraordinary response and survival in patients with cancer.

Authors:  Flurina A M Saner; Alan Herschtal; Brad H Nelson; Anna deFazio; Ellen L Goode; Susan J Ramus; Ahwan Pandey; Jessica A Beach; Sian Fereday; Andrew Berchuck; Stephanie Lheureux; Celeste Leigh Pearce; Paul D Pharoah; Malcolm C Pike; Dale W Garsed; David D L Bowtell
Journal:  Nat Rev Cancer       Date:  2019-06       Impact factor: 60.716

6.  A comprehensive gene-environment interaction analysis in Ovarian Cancer using genome-wide significant common variants.

Authors:  Sehee Kim; Miao Wang; Jonathan P Tyrer; Allan Jensen; Ashley Wiensch; Gang Liu; Alice W Lee; Roberta B Ness; Maxwell Salvatore; Shelley S Tworoger; Alice S Whittemore; Hoda Anton-Culver; Weiva Sieh; Sara H Olson; Andrew Berchuck; Ellen L Goode; Marc T Goodman; Jennifer Anne Doherty; Georgia Chenevix-Trench; Mary Anne Rossing; Penelope M Webb; Graham G Giles; Kathryn L Terry; Argyrios Ziogas; Renée T Fortner; Usha Menon; Simon A Gayther; Anna H Wu; Honglin Song; Angela Brooks-Wilson; Elisa V Bandera; Linda S Cook; Daniel W Cramer; Roger L Milne; Stacey J Winham; Susanne K Kjaer; Francesmary Modugno; Pamela J Thompson; Jenny Chang-Claude; Holly R Harris; Joellen M Schildkraut; Nhu D Le; Nico Wentzensen; Britton Trabert; Estrid Høgdall; David Huntsman; Malcolm C Pike; Paul D P Pharoah; Celeste Leigh Pearce; Bhramar Mukherjee
Journal:  Int J Cancer       Date:  2019-01-20       Impact factor: 7.396

7.  Evidence of a genetic link between endometriosis and ovarian cancer.

Authors:  Alice W Lee; Claire Templeman; Douglas A Stram; Jonathan Beesley; Jonathan Tyrer; Andrew Berchuck; Paul P Pharoah; Georgia Chenevix-Trench; Celeste Leigh Pearce
Journal:  Fertil Steril       Date:  2015-10-23       Impact factor: 7.329

8.  Population distribution of lifetime risk of ovarian cancer in the United States.

Authors:  Malcolm C Pike; Paul D P Pharoah; Celeste Leigh Pearce; Daniel O Stram; Roberta B Ness; Douglas A Stram; Lynda D Roman; Claire Templeman; Alice W Lee; Usha Menon; Peter A Fasching; Jessica N McAlpine; Jennifer A Doherty; Francesmary Modugno; Joellen M Schildkraut; Mary Anne Rossing; David G Huntsman; Anna H Wu; Andrew Berchuck
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2015-01-26       Impact factor: 4.254

9.  Robust Tests for Additive Gene-Environment Interaction in Case-Control Studies Using Gene-Environment Independence.

Authors:  Gang Liu; Bhramar Mukherjee; Seunggeun Lee; Alice W Lee; Anna H Wu; Elisa V Bandera; Allan Jensen; Mary Anne Rossing; Kirsten B Moysich; Jenny Chang-Claude; Jennifer A Doherty; Aleksandra Gentry-Maharaj; Lambertus Kiemeney; Simon A Gayther; Francesmary Modugno; Leon Massuger; Ellen L Goode; Brooke L Fridley; Kathryn L Terry; Daniel W Cramer; Susan J Ramus; Hoda Anton-Culver; Argyrios Ziogas; Jonathan P Tyrer; Joellen M Schildkraut; Susanne K Kjaer; Penelope M Webb; Roberta B Ness; Usha Menon; Andrew Berchuck; Paul D Pharoah; Harvey Risch; Celeste Leigh Pearce
Journal:  Am J Epidemiol       Date:  2018-02-01       Impact factor: 4.897

10.  Assessment of Multifactor Gene-Environment Interactions and Ovarian Cancer Risk: Candidate Genes, Obesity, and Hormone-Related Risk Factors.

Authors:  Joseph L Usset; Rama Raghavan; Jonathan P Tyrer; Valerie McGuire; Weiva Sieh; Penelope Webb; Jenny Chang-Claude; Anja Rudolph; Hoda Anton-Culver; Andrew Berchuck; Louise Brinton; Julie M Cunningham; Anna DeFazio; Jennifer A Doherty; Robert P Edwards; Simon A Gayther; Aleksandra Gentry-Maharaj; Marc T Goodman; Estrid Høgdall; Allan Jensen; Sharon E Johnatty; Lambertus A Kiemeney; Susanne K Kjaer; Melissa C Larson; Galina Lurie; Leon Massuger; Usha Menon; Francesmary Modugno; Kirsten B Moysich; Roberta B Ness; Malcolm C Pike; Susan J Ramus; Mary Anne Rossing; Joseph Rothstein; Honglin Song; Pamela J Thompson; David J van den Berg; Robert A Vierkant; Shan Wang-Gohrke; Nicolas Wentzensen; Alice S Whittemore; Lynne R Wilkens; Anna H Wu; Hannah Yang; Celeste Leigh Pearce; Joellen M Schildkraut; Paul Pharoah; Ellen L Goode; Brooke L Fridley
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2016-03-14       Impact factor: 4.254

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.